002349.SZ Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 03:04):

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China...

Stats
Today's Volume	12.87M
Average Volume	14.50M
Market Cap	5.77B
EPS	CNY0.0500 ( 2023-09-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	24.52
ATR14	CNY0.0110 (0.15%)

Volume Correlation

Long: 0.00 (neutral)

Short: -0.50 (weak negative)

Signal:(35.923) Neutral

Jinghua Pharmaceutical Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jinghua Pharmaceutical Correlation - Currency/Commodity

0.68
( moderate )

0.72
( moderate )

0.00
( neutral )

0.50
( weak )

0.00
( neutral )

-0.63
( weak negative )

Jinghua Pharmaceutical Financials

Annual	2022
Revenue:	CNY1.57B
Gross Profit:	CNY735.15M (46.73 %)
EPS:	CNY0.260

Q3	2023
Revenue:	CNY324.31M
Gross Profit:	CNY154.68M (47.69 %)
EPS:	CNY0.0500

Q2	2023
Revenue:	CNY378.99M
Gross Profit:	CNY179.93M (47.48 %)
EPS:	CNY0.0822

Q1	2023
Revenue:	CNY416.36M
Gross Profit:	CNY209.85M (50.40 %)
EPS:	CNY0.110

Financial Reports:

No articles found.

Jinghua Pharmaceutical

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. Jinghua Pharmaceutical Group Co., Ltd. was founded in 1957 and is based in Nantong, China.